VR Adviser’s Korro Bio KRRO Stock Holding History

VR Adviser’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3M	Hold	1,009,500	–	–	0.4%	29
2026 Q1	$11.4M	Buy	+1,009,500	New	+$11.1M	0.43%	30

Other funds holding KRRO

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VR Adviser's KRRO Position: Q2 2026 in Review

VR Adviser held its Korro Bio (KRRO) position steady in Q2 2026 at 1,009,500 shares worth $13.3M. The position accounts for 0.4% of the portfolio, ranked #29.

VR Adviser first reported a position in KRRO in Q1 2026 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

VR Adviser held 1,009,500 shares of Korro Bio worth $13.3M as of Q2 2026.
VR Adviser left its Korro Bio share count unchanged in Q2 2026.
Korro Bio made up 0.4% of VR Adviser's portfolio in Q2 2026, its #29 holding.
VR Adviser first reported a position in Korro Bio in Q1 2026 and has held it in 2 quarters since.
107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on VR Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.